Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Nutritional Supplements in Nasopharyngeal Carcinoma
NCT04823468Completed
- Start
- Jul 2021
- Primary completion
- May 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms). Primary endpoint: Incidence of weight loss > 5% up to 7 weeks. Started Jul 2021; status: completed.
Beyond the preview
Go deeper on NCT04823468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04823468.